Table 2.
Characteristics | n | 5-year survival (%) |
p-value | |
---|---|---|---|---|
<16ng/ml | ≥16ng/ml | |||
Vitamin D | 303 | 64.3 | 83.5 | 0.002 |
Age (years) | 0.003 | |||
<50 | 143 | 80.8 | 89 | |
≥50 | 159 | 54 | 78.2 | |
BMI 23 kg/m2 | 0.007 | |||
<23 | 128 | 81.3 | 75.1 | |
≥23 | 167 | 51.9 | 91.9 | |
Clinical stage | 0.024 | |||
I-II | 189 | 81.8 | 92.6 | |
III-IV | 83 | 42.9 | 61.3 | |
LN metastasis | 0.001 | |||
Positive | 117 | 45 | 72.2 | |
Negative | 111 | 87.5 | 96.5 | |
ER | 0.001 | |||
Positive | 170 | 52.1 | 86.2 | |
Negative | 92 | 70 | 77.7 | |
PgR | 0.001 | |||
Positive | 129 | 61.9 | 90.3 | |
Negative | 133 | 57.1 | 76.2 | |
HER-2 | 0.012 | |||
Positive | 49 | 62.5 | 70.6 | |
Equivocal | 52 | 75 | 76 | |
Negative | 154 | 51.1 | 88.2 | |
P53 | 0.001 | |||
Positive | 206 | 65.5 | 85.7 | |
Negative | 58 | 50 | 75.6 | |
Ki-67 | 0.027 | |||
Positive | 238 | 67.9 | 82.9 | |
Negative | 17 | 66.7 | 85.7 |